Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis

Overview of attention for article published in Journal of Translational Medicine, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet

twitter: 16 X users

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 20 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis

Doc Wire News, 04 Jan 2022

This article was originally published here J Transl Med. 2022 Jan 3;20(1):3. doi: 10.1186/s12967-021-03205-6.

Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis

Doc Wire News, 04 Jan 2022

This article was originally published here J Transl Med. 2022 Jan 3;20(1):3. doi: 10.1186/s12967-021-03205-6.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.